Nova Leap Health Corp. NLH.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.11% | 10.69% | 22.81% | 29.00% | 26.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.11% | 10.69% | 22.81% | 29.00% | 26.55% |
| Cost of Revenue | 16.88% | 9.08% | 21.33% | 25.65% | 22.92% |
| Gross Profit | 17.45% | 13.21% | 25.10% | 34.46% | 32.36% |
| SG&A Expenses | 7.07% | 7.91% | 25.40% | 26.02% | 30.03% |
| Depreciation & Amortization | -14.41% | -24.39% | 30.73% | 59.64% | 50.40% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.62% | 7.73% | 22.96% | 26.58% | 25.94% |
| Operating Income | 115.38% | 287.23% | 18.40% | 101.15% | 41.46% |
| Income Before Tax | 252.62% | 694.90% | -105.91% | 496.55% | -281.58% |
| Income Tax Expenses | 346.46% | 7,150.00% | -105.24% | 168.28% | -203.17% |
| Earnings from Continuing Operations | 234.30% | 514.56% | -106.06% | 305.00% | -313.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 234.30% | 514.56% | -106.06% | 305.00% | -313.22% |
| EBIT | 115.38% | 287.23% | 18.40% | 101.15% | 41.46% |
| EBITDA | 66.89% | 61.86% | 31.99% | 84.02% | 44.67% |
| EPS Basic | 234.55% | 511.11% | -105.61% | 304.17% | -311.54% |
| Normalized Basic EPS | 266.67% | 1,750.00% | -104.55% | 2,350.00% | -244.44% |
| EPS Diluted | 216.67% | 470.00% | -105.88% | 304.17% | -330.77% |
| Normalized Diluted EPS | 264.10% | 1,750.00% | -104.65% | 2,350.00% | -244.44% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 9.14% | 1.28% | -0.24% |
| Average Diluted Shares Outstanding | 1.09% | 0.79% | 6.79% | 2.02% | -0.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |